Jonathan Aschoff
Stock Analyst at Roth MKM
(0.02)
# 4,405
Out of 4,407 analysts
433
Total ratings
30.2%
Success rate
-20.3%
Average return
Main Sectors:
Stocks Rated by Jonathan Aschoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GOVX GeoVax Labs | Maintained: Buy | $10 | $1.22 | +719.67% | 15 | May 26, 2026 | |
| BFRI Biofrontera | Maintained: Buy | $9 | $0.8651 | +940.34% | 12 | May 15, 2026 | |
| PTHS Pelthos Therapeutics | Maintained: Buy | $55 | $27.50 | +100.00% | 5 | May 15, 2026 | |
| APVO Aptevo Therapeutics | Maintained: Buy | $21 | $4.78 | +339.33% | 10 | May 14, 2026 | |
| CLNN Clene | Maintained: Buy | $30 | $5.84 | +413.70% | 6 | May 14, 2026 | |
| REVB Revelation Biosciences | Maintained: Buy | $16 | $0.9963 | +1,505.94% | 13 | May 8, 2026 | |
| MDCX Medicus Pharma | Maintained: Buy | $9 | $0.3377 | +2,565.09% | 2 | May 7, 2026 | |
| CLRB Cellectar Biosciences | Rated: Buy | $14 → $11 | $2.23 | +393.27% | 10 | May 5, 2026 | |
| CELZ Creative Medical Technology Holdings | Maintained: Buy | $20 | $2.17 | +821.66% | 7 | Apr 28, 2026 | |
| BRTX BioRestorative Therapies | Maintained: Buy | $18 → $15 | $0.3525 | +4,155.32% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $3 | $0.447 | +571.14% | 5 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $2.64 | +1,074.24% | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $12.65 | +66.01% | 15 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $3 | $0.0001 | +2,999,900.00% | 8 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $2 | $0.038 | n/a | 11 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $11.48 | n/a | 7 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $0.143 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | $3.14 | n/a | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $10.71 | n/a | 1 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7818 | n/a | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.60 | $0.091 | n/a | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 | $5.27 | n/a | 9 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $36 | $24.75 | n/a | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 → $24 | $1.54 | n/a | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $620 → $500 | $0.000001 | n/a | 3 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $8.45 | n/a | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.21 | n/a | 1 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $30 | $0.1831 | n/a | 3 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.458 | n/a | 5 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2.5 → $8 | $0.0001 | n/a | 5 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.0001 | n/a | 4 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $38 | $10.43 | n/a | 1 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $0.0002 | n/a | 3 | Nov 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $1.10 | n/a | 17 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $11 | $2.72 | n/a | 3 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $26 | $1.24 | n/a | 2 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.803 | n/a | 1 | Apr 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.001 | n/a | 8 | Sep 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.71 | n/a | 12 | Sep 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $0.4001 | n/a | 17 | Sep 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $255.17 | n/a | 5 | Aug 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $92 | $108.53 | n/a | 14 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $0.3998 | n/a | 10 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $16 | $31.27 | n/a | 11 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $0.6248 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $49.52 | n/a | 21 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $0.9245 | n/a | 12 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $4.23 | n/a | 6 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $22.99 | n/a | 16 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $59.38 | n/a | 13 | Aug 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.000001 | n/a | 10 | Jul 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $489 | $612.14 | n/a | 18 | Mar 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.43 | n/a | 4 | Nov 12, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $0.7411 | n/a | 3 | Dec 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $55.95 | n/a | 3 | Oct 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $545.96 | n/a | 1 | Feb 26, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $2.02 | n/a | 1 | Jan 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.06 | n/a | 2 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $69.50 | n/a | 2 | Apr 16, 2012 |
GeoVax Labs
May 26, 2026
Maintained: Buy
Price Target: $10
Current: $1.22
Upside: +719.67%
Biofrontera
May 15, 2026
Maintained: Buy
Price Target: $9
Current: $0.8651
Upside: +940.34%
Pelthos Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $55
Current: $27.50
Upside: +100.00%
Aptevo Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $21
Current: $4.78
Upside: +339.33%
Clene
May 14, 2026
Maintained: Buy
Price Target: $30
Current: $5.84
Upside: +413.70%
Revelation Biosciences
May 8, 2026
Maintained: Buy
Price Target: $16
Current: $0.9963
Upside: +1,505.94%
Medicus Pharma
May 7, 2026
Maintained: Buy
Price Target: $9
Current: $0.3377
Upside: +2,565.09%
Cellectar Biosciences
May 5, 2026
Rated: Buy
Price Target: $14 → $11
Current: $2.23
Upside: +393.27%
Creative Medical Technology Holdings
Apr 28, 2026
Maintained: Buy
Price Target: $20
Current: $2.17
Upside: +821.66%
BioRestorative Therapies
Apr 2, 2026
Maintained: Buy
Price Target: $18 → $15
Current: $0.3525
Upside: +4,155.32%
Mar 2, 2026
Maintained: Buy
Price Target: $8 → $3
Current: $0.447
Upside: +571.14%
Feb 23, 2026
Maintained: Buy
Price Target: $31
Current: $2.64
Upside: +1,074.24%
Jul 22, 2025
Maintained: Buy
Price Target: $21
Current: $12.65
Upside: +66.01%
Jul 8, 2025
Maintained: Buy
Price Target: $4 → $3
Current: $0.0001
Upside: +2,999,900.00%
Jun 4, 2025
Maintained: Buy
Price Target: $9 → $2
Current: $0.038
Upside: n/a
May 15, 2025
Maintained: Buy
Price Target: $30
Current: $11.48
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $13 → $11
Current: $0.143
Upside: n/a
May 12, 2025
Maintained: Buy
Price Target: €12.00
Current: $3.14
Upside: n/a
Oct 28, 2024
Maintained: Buy
Price Target: $20
Current: $10.71
Upside: n/a
Oct 23, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.7818
Upside: n/a
Sep 3, 2024
Maintained: Buy
Price Target: $0.60
Current: $0.091
Upside: n/a
May 21, 2024
Rated: Buy
Price Target: $36
Current: $5.27
Upside: n/a
Mar 7, 2024
Maintained: Buy
Price Target: $25 → $36
Current: $24.75
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: $250 → $24
Current: $1.54
Upside: n/a
Dec 18, 2023
Maintained: Buy
Price Target: $620 → $500
Current: $0.000001
Upside: n/a
Feb 27, 2023
Maintained: Buy
Price Target: $14
Current: $8.45
Upside: n/a
Jun 15, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $1.21
Upside: n/a
Apr 28, 2022
Maintained: Buy
Price Target: $4 → $30
Current: $0.1831
Upside: n/a
Oct 25, 2021
Reiterated: Buy
Price Target: $24
Current: $0.458
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $2.5 → $8
Current: $0.0001
Upside: n/a
Aug 30, 2021
Maintained: Buy
Price Target: $7
Current: $0.0001
Upside: n/a
Mar 11, 2021
Initiated Coverage: Buy
Price Target: $38
Current: $10.43
Upside: n/a
Nov 22, 2020
Maintained: Buy
Price Target: $18
Current: $0.0002
Upside: n/a
Nov 17, 2020
Downgraded: Sell
Price Target: $8
Current: $1.10
Upside: n/a
Oct 14, 2020
Reiterated: Buy
Price Target: $14 → $11
Current: $2.72
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: $13 → $26
Current: $1.24
Upside: n/a
Apr 20, 2020
Reiterated: Buy
Price Target: $9
Current: $0.803
Upside: n/a
Sep 15, 2016
Reiterated: Buy
Price Target: $14
Current: $0.001
Upside: n/a
Sep 13, 2016
Reiterated: Buy
Price Target: $4
Current: $1.71
Upside: n/a
Sep 9, 2016
Reiterated: Buy
Price Target: $55
Current: $0.4001
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $29
Current: $255.17
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $92
Current: $108.53
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $24
Current: $0.3998
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $24 → $16
Current: $31.27
Upside: n/a
Aug 9, 2016
Reiterated: Sell
Price Target: $4 → $3
Current: $0.6248
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $28
Current: $49.52
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $26
Current: $0.9245
Upside: n/a
Aug 9, 2016
Reiterated: Buy
Price Target: $16
Current: $4.23
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: n/a
Current: $22.99
Upside: n/a
Aug 4, 2016
Reiterated: Buy
Price Target: $16 → $18
Current: $59.38
Upside: n/a
Jul 6, 2016
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Mar 8, 2016
Initiated Coverage: Buy
Price Target: $489
Current: $612.14
Upside: n/a
Nov 12, 2015
Reiterated: Buy
Price Target: $5
Current: $0.43
Upside: n/a
Dec 8, 2014
Maintained: Buy
Price Target: $16
Current: $0.7411
Upside: n/a
Oct 24, 2014
Maintained: Hold
Price Target: n/a
Current: $55.95
Upside: n/a
Feb 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $545.96
Upside: n/a
Jan 17, 2013
Downgraded: Sell
Price Target: $1
Current: $2.02
Upside: n/a
Jun 29, 2012
Reiterated: Buy
Price Target: n/a
Current: $23.06
Upside: n/a
Apr 16, 2012
Maintained: Buy
Price Target: $13 → $11
Current: $69.50
Upside: n/a